ResearcherKochi Health Sciences CenterNo recent work listed

Takatsugu Matsumoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6132-7283; OpenAlex author ID A5075223906. Sources: OpenAlex.

Their work

Papers: 6
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2020: 1 paper · 2021: 5 papers

Papers 6

Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00280-021-04267-5 ↗
A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. Co-author DOI 10.1007/s00423-021-02167-z ↗
Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001826 ↗
Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14925 ↗
Clinical Predictors of Unresectable Disease at Laparotomy in Patients With Pancreatic Ductal Adenocarcinoma Planning to Undergo Surgical Resection. Co-author DOI 10.21873/anticanres.15335 ↗
Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreatic cancer patients. Co-author DOI 10.1016/j.amjsurg.2019.04.014 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Keiichi Kubota · 5 shared papers, 2021 · strength 0.65
Takayuki Shimizu · 4 shared papers, 2021 · strength 0.51
Taku Aoki · 4 shared papers, 2021 · strength 0.51
Shozo Mori · 4 shared papers, 2021 · strength 0.51
Jun Iwata · 2 shared papers, 2020–2021 · strength 0.27
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014 ↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z ↗
Takehiro Okabayashi · 2 shared papers, 2020–2021 · strength 0.27
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014 ↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z ↗
Yasuhiro Shimada · 2 shared papers, 2020–2021 · strength 0.27
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014 ↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z ↗
Kenta Sui · 2 shared papers, 2020–2021 · strength 0.27
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014 ↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z ↗
Tatsuo Iiyama · 1 shared paper, 2021 · strength 0.13
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.